COMMUNIQUÉS West-GlobeNewswire

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
24/04/2026
BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Alvotech to Report Financial Results for the First Quarter of 2026
24/04/2026
REYKJAVIK, ICELAND (April 24, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Alvotech to Report Financial Results for the First Quarter of 2026
24/04/2026
REYKJAVIK, Iceland, April 24, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML
24/04/2026
– Regulatory Filing in Japan Planned Following Clinical Trial Completion – TOKYO and SAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura Oncology, Inc. (Nasdaq: KURA [...]
Media Advisory-Ontario Health Coalition/Large cross-province protests this Saturday: Ford gov’t pushing our hospitals into deficit & cuts while paying more to privatize their services
24/04/2026
TORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- On Saturday, April 25, local residents in seven communities will send a loud and clear message to the Ford government, as follows: Ottawa : 12 pm at the Human Rights Monument [...]
Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada
24/04/2026
BOCA RATON, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announced its intention to seek [...]
Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy
24/04/2026
AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today provided a [...]
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
24/04/2026
- Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius Medical Care - - Positions Humacyte to advance discussions with corporate partners regarding international and indication-specific [...]
Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program
24/04/2026
Cambridge, UK, 24 th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the presentation of new [...]
Free Carotenoid Eye Screenings Offered to Seacoast Residents Near Portsmouth, NH
24/04/2026
Fox Run Eye Care launches free carotenoid screenings for Seacoast families — and brings 25 years of patient-first optometry to a stunning new vision center in Greenland, NH GREENLAND, N.H., April 24, 2026 (GLOBE [...]
30 Years of Smiles: St. Augustine’s Premier Cosmetic Dentist Marks a Career Built on Artistry
24/04/2026
Dr. Atosa Khan celebrates three decades of dental excellence and 20 years of independent practice at one of Northeast Florida’s most distinguished dental offices ST. AUGUSTINE, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- [...]
Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification
24/04/2026
Majority-owned PrestoDoctor platform operates within state-regulated medical cannabis frameworks as federal classification evolves Mesquite, NV, April 24, 2026 (GLOBE NEWSWIRE) -- Mesquite, Nevada - Dogecoin Cash, Inc [...]
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
24/04/2026
PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
24/04/2026
The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out Eversense 365 doubles sensor lifespan from the previously [...]
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
24/04/2026
PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its first quarter 2026 financial results on Friday, May 8, [...]
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
24/04/2026
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its first [...]
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées
24/04/2026
Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées [...]
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
24/04/2026
If approved, Itvisma (intrathecal onasemnogene abeparvovec) will be first and only gene replacement therapy for children two years and older, teens and adults with SMA in the European Union Itvisma demonstrated [...]
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
24/04/2026
Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Recommendation based on the HERCULES phase 3 study which demonstrated that [...]

Pages